Alvogen is an American pharmaceuticals company founded in 2009.
Alvogen is an international, privately-owned specialty pharmaceutical company focused on the development, manufacturing, and marketing of generic pharmaceuticals, biosimilar products, and OTC (over-the-counter medicines). Alvogen’s lines of business include generic sales and marketing (Gx), product development, contract manufacturing (CMO), and contract research (CRO).
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Feb 1, 2022
OLIPOP
|
Series B | $30M | Food and Beverage | — |
Oct 4, 2021
Inkitt
|
Series B | $59M | Analytics | — |
Oct 27, 2020
Alvotech
|
Series Unknown | $65M | Biotechnology | — |
Jan 20, 2016
Citymapper
|
Series B | $40M | Big Data | — |